Cordyceps militaris polysaccharides modulate gut microbiota and improve metabolic disorders in mice with diet‐induced obesity
Journal of the Science of Food and Agriculture · 2023
DOI: 10.1002/jsfa.12409 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the Science of Food and Agriculture, 2023. Verfasst von Shishi Huang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Food Biotechnology, College of Food Science, South China Agricultural University, Guangzhou, China. Hauptthemen laut MEDLINE: Cordyceps, Gastrointestinal Microbiome, Metabolic Diseases. Die Arbeit wurde bisher 38-mal zitiert (Crossref) und nennt 38 Literaturangaben. Gefördert von: Guangdong Basic and Applied Basic Research Foundation, Guangdong Province Agriculture Research Project & Agricultural Technique Promotion Project, National Natural Science Foundation of China.
Abstract (Originalsprache)
BACKGROUND Cordyceps militaris is an edible and medicinal fungus, and its polysaccharides are among its main pharmacological components. They can display immunomodulation, anti‐oxidation, anti‐inflammation, anti‐hypolipidemic, and other functions. The anti‐obesity effect of C. militaris polysaccharides (CMP) is not yet fully understood, however. RESULTS In this study, a CMP diet intervention was applied over a 4 week period to mice with obesity induced by a high‐fat diet (HFD), followed by profiling of obesity‐induced dyslipidemia, low‐grade inflammation, and gut dysbiosis. The results suggested that CMP could significantly reduce HFD‐induced obesity, alleviate obesity‐induced hyperlipidemia and insulin resistance, and ameliorate systemic inflammation, showing a promising ability to protect mice from obesity. Further analyses revealed that CMP could regulate obesity‐induced gut dysbiosis by restoring the phylogenetic diversity of gut microbiota. It could also increase the relative abundance of short‐chain fatty acid (SCFA)‐producing bacteria, while down‐regulating the level of bacteria that were positively related to the development of obesity. A correlation analysis showed that Helicobacter , Allobaculum , Clostridium XVIII, Parabacteroides , Ligilactobacillus , Faecalibaculum , Adlercreutzia , and Mediterraneibacter were positively related to obese phenotypes. CONCLUSION This study highlights the potential of CMP as a prebiotic agent to protect obese individuals from metabolic disorders and gut dysbiosis. © 2022 Society of Chemical Industry.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Food Biotechnology, College of Food Science, South China Agricultural University, Guangzhou, China.
- Research Center for Micro-Ecological Agent Engineering and Technology of Guangdong Province, Guangzhou, China.
ORCID-Profile: Yuan Zou, Zhiwei Ye, Tao Wei, Junfang Lin, Qianwang Zheng
Förderung
- Guangdong Basic and Applied Basic Research Foundation
- Guangdong Province Agriculture Research Project & Agricultural Technique Promotion Project
- National Natural Science Foundation of China
- Research Foundation
Zitieren
APA
Huang, S., Zou, Y., Tang, H., Zhuang, J., Ye, Z., Wei, T., Lin, J., & Zheng, Q. (2023). Cordyceps militaris polysaccharides modulate gut microbiota and improve metabolic disorders in mice with diet‐induced obesity. Journal of the Science of Food and Agriculture. https://doi.org/10.1002/jsfa.12409
Vancouver
Huang S, Zou Y, Tang H, Zhuang J, Ye Z, Wei T, et al. Cordyceps militaris polysaccharides modulate gut microbiota and improve metabolic disorders in mice with diet‐induced obesity. Journal of the Science of Food and Agriculture. 2023. doi:10.1002/jsfa.12409
BibTeX
@article{Huang2023,
author = {Huang, Shishi and Zou, Yuan and Tang, Hongbiao and Zhuang, Jingyu and Ye, Zhiwei and Wei, Tao and Lin, Junfang and Zheng, Qianwang},
title = {Cordyceps militaris polysaccharides modulate gut microbiota and improve metabolic disorders in mice with diet‐induced obesity},
journal = {Journal of the Science of Food and Agriculture},
year = {2023},
doi = {10.1002/jsfa.12409}
}
EUVIMED